Malignancy characteristics |
Malignancy
characteristics |
Malignancy characteristics |
Number
(%) |
No. of lesion |
1 |
1 |
15 (27.78) |
|
2 |
2 |
8 (14.81) |
|
3 |
3 |
12 (22.22) |
|
>3 |
>3 |
19 (35.19) |
Lobe of liver |
Right |
Right |
30 (55.56) |
|
Left |
Left |
8 (14.81) |
|
Both |
Both |
16 (29.63) |
CTP status |
A |
A |
23 (42.59) |
|
B |
B |
14 (25.93) |
|
C |
C |
17 (31.48) |
ECOG performance status |
0 |
0 |
20 (37.04) |
|
1 |
1 |
8 (14.81) |
|
2 |
2 |
11 (20.37) |
|
3 |
3 |
11 (20.37) |
|
4 |
4 |
4 (7.41) |
BCLC Staging |
0 |
0 |
0 |
|
A |
A |
8 (14.81) |
|
B |
B |
6 (11.11) |
|
C |
C |
19 (35.19) |
|
D |
D |
21 (38.89) |
Distant metastasis |
Yes |
Yes |
8 (14.81) |
|
No |
No |
46 (85.19) |
Portal vein thrombosis |
Yes |
Yes |
24 (44.44) |
|
No |
No |
30 (55.56) |
AKI |
Yes |
Yes |
8 (18.81) |
|
No |
No |
46 (85.19) |
AFP elevated |
Yes |
Yes |
44 (81.48) |
|
No |
No |
10 (18.52) |
Liver status |
Cirrhotic |
Decompensated |
34 (62.97) |
|
|
Compensated |
8 (14.81) |
|
Non-cirrhotic |
Non-cirrhotic |
12 (22.22) |